FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:944 October 5, 1995 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Attention deficit–hyperactivity disorder (ADHD) is considered to be the most common neurobehavioral disorder of childhood,¹ but there are no firm estimates of its prevalence. Dramatic increases have been reported in the frequency of the diagnosis of ADHD and the prescription of methylphenidate,² a stimulant drug used for decades to treat this disorder,³ but these increases have not been verified.

We used a commercial data base on physicians' diagnosis and prescription practices⁴ to estimate the frequency of the diagnosis and treatment of ADHD, and a United Nations report on Schedule II drugs⁵ to document the production rate of . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Scheffler, R. M., Hinshaw, S. P., Modrek, S., Levine, P. (2007). The Global Market For ADHD Medications. Health Aff (Millwood) 26: 450-457 [Abstract] [Full Text]  
• Greenhill, L. L., Pliszka, S., Dulcan, M. K., Bernet, W., Arnold, V., Beitchman, J., Benson, R. S., Bukstein, O., Kinlan, J., McClellan, J., Rue, D., Shaw, J. A., Stock, S. (2004). Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults. Focus 2: 642-668 [Abstract] [Full Text]  
• Swanson, J., Gupta, S., Lam, A., Shoulson, I., Lerner, M., Modi, N., Lindemulder, E., Wigal, S. (2003). Development of a New Once-a-Day Formulation of Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder: Proof-of-Concept and Proof-of-Product Studies. Arch Gen Psychiatry 60: 204-211 [Abstract] [Full Text]  
• Le Nedelec, M J, Rosengren, R J (2002). Methylphenidate inhibits cytochrome P450 in the Swiss Webster mouse. Hum Exp Toxicol 21: 273-280 [Abstract]  
• Schirm, E., Tobi, H., Zito, J. M., de Jong-van den Berg, L. T. W. (2001). Psychotropic Medication in Children: A Study From The Netherlands. Pediatrics 108 : e25-e25 [Abstract] [Full Text]  
• Goldstein, S., Turner, D. (2001). The extent of drug therapy for ADHD among children in a large public school district. J Atten Disord 4: 212-219 [Abstract]  
• White, S. R., Yadao, C. M. (2000). Characterization of Methylphenidate Exposures Reported to a Regional Poison Control Center. Arch Pediatr Adolesc Med 154: 1199-1203 [Abstract] [Full Text]  
• Eghbalieh, B., Crinella, F. M., Hunt, L. E., Swanson, J. M. (2000). Prenatal stimulant exposure affects alerting and executive control in six and seven-year-olds. J Atten Disord 4: 5-13 [Abstract]  
• Zito, J. M., Safer, D. J., dosReis, S., Magder, L. S., Gardner, J. F., Zarin, D. A. (1999). Psychotherapeutic Medication Patterns for Youths With Attention-Deficit/Hyperactivity Disorder. Arch Pediatr Adolesc Med 153: 1257-1263 [Abstract] [Full Text]  
• Rappley, M. D., Mullan, P. B., Alvarez, F. J., Eneli, I. U., Wang, J., Gardiner, J. C. (1999). Diagnosis of Attention-Deficit/Hyperactivity Disorder and Use of Psychotropic Medication in Very Young Children. Arch Pediatr Adolesc Med 153: 1039-1045 [Abstract] [Full Text]  
• Robison, L. M., Sclar, D. A., Skaer, T. L., Galin, R. S. (1999). National Trends in the Prevalence of Attention-Deficit/Hyperactivity Disorder and the Prescribing of Methylphenidate among School-Age Children: 1990-1995. CLIN PEDIATR 38: 209-217 [Abstract]  
• Pelham, W. E., Aronoff, H. R., Midlam, J. K., Shapiro, C. J., Gnagy, E. M., Chronis, A. M., Onyango, A. N., Forehand, G., Nguyen, A., Waxmonsky, J. (1999). A Comparison of Ritalin and Adderall: Efficacy and Time-course in Children With Attention-deficit/Hyperactivity Disorder. Pediatrics 103: 43e-43 [Abstract] [Full Text]  
• Elia, J., Ambrosini, P. J., Rapoport, J. L. (1999). Treatment of Attention-Deficit-Hyperactivity Disorder. NEJM 340: 780-788 [Full Text]  
• Prosser, B., Reid, R. (1999). Psychostimulant Use for Children with ADHD in Australia. Journal of Emotional and Behavioral Disorders 7: 110-117 [Abstract]  
• Volkow, N. D., Wang, Gene.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., Pappas, N. (1998). Dopamine Transporter Occupancies in the Human Brain Induced by Therapeutic Doses of Oral Methylphenidate. Am. J. Psychiatry 155: 1325-1331 [Abstract] [Full Text]  
• Goldman, L. S., Genel, M., Bezman, R. J., Slanetz, P. J., for the Council on Scientific Affairs, American Me, (1998). Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. JAMA 279: 1100-1107 [Abstract] [Full Text]  
• Pincus, H. A., Tanielian, T. L., Marcus, S. C., Olfson, M., Zarin, D. A., Thompson, J., Zito, J. M. (1998). Prescribing Trends in Psychotropic Medications: Primary Care, Psychiatry, and Other Medical Specialties. JAMA 279: 526-531 [Abstract] [Full Text]  
• Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y.-S., Gatley, S. J., Gifford, A., Franceschi, D. (2001). Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain. J. Neurosci. 21: RC121-RC121 [Abstract] [Full Text]